DekaBank Deutsche Girozentrale - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$372,000
-49.0%
19,800
-69.3%
0.00%
-50.0%
Q2 2019$730,000
+69.0%
64,600
+166.9%
0.00%
+33.3%
Q1 2019$432,000
+112.8%
24,200
+22.2%
0.00%
+200.0%
Q4 2018$203,000
-53.0%
19,800
-18.2%
0.00%
-66.7%
Q3 2018$432,000
+10.5%
24,200
-2.4%
0.00%0.0%
Q2 2018$391,000
+30.3%
24,8000.0%0.00%
+50.0%
Q1 2018$300,000
+28.2%
24,800
-2.0%
0.00%0.0%
Q4 2017$234,0000.0%25,3000.0%0.00%0.0%
Q3 2017$234,000
-23.0%
25,3000.0%0.00%0.0%
Q2 2017$304,000
-43.0%
25,3000.0%0.00%
-60.0%
Q1 2017$533,000
-7.3%
25,300
-8.0%
0.01%
-16.7%
Q4 2016$575,000
-27.7%
27,500
+8.3%
0.01%
-33.3%
Q3 2016$795,000
+28.6%
25,4000.0%0.01%
+28.6%
Q2 2016$618,000
+40.8%
25,400
+35.1%
0.01%
+40.0%
Q1 2016$439,000
-41.6%
18,800
-14.9%
0.01%
-44.4%
Q4 2015$752,000
+5.8%
22,100
+1.8%
0.01%0.0%
Q3 2015$711,000
-27.1%
21,700
+17.9%
0.01%
-25.0%
Q2 2015$975,000
+89.7%
18,400
+3.4%
0.01%
+100.0%
Q1 2015$514,00017,8000.01%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 2,942,130$37,365,0008.14%
Foresite Capital Management II, LLC 1,686,220$21,415,0007.12%
Foresite Capital Management IV, LLC 830,919$10,553,0004.38%
SENZAR ASSET MANAGEMENT, LLC 822,890$10,451,0003.30%
Redmile Group, LLC 6,505,766$82,623,0003.19%
DAFNA Capital Management LLC 396,013$5,029,0002.45%
SECTORAL ASSET MANAGEMENT INC 863,600$10,968,0001.20%
Palo Alto Investors LP 1,849,832$23,493,0001.00%
Bellevue Group AG 700,464$8,896,0000.88%
Rock Springs Capital Management LP 1,529,800$19,428,0000.83%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders